Some 30 million Americans take GLP-1 medications like Ozempic and Mounjaro, shelling out hundreds of dollars in monthly fees even with health insurance.
But experts warn patients could see those costs double, if employers drop coverage.
Some 30 million Americans take GLP-1 medications like Ozempic and Mounjaro, shelling out hundreds of dollars in monthly fees even with health insurance.
But experts warn patients could see those costs double, if employers drop coverage.